Detalles de la búsqueda
1.
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies.
Blood
; 142(6): 553-560, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257195
2.
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Eur J Nucl Med Mol Imaging
; 50(2): 486-493, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166080
3.
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Cancer
; 128(24): 4285-4295, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36281718
4.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eur J Nucl Med Mol Imaging
; 49(3): 932-942, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405277
5.
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Eur J Nucl Med Mol Imaging
; 49(13): 4642-4651, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35925442
6.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539742
7.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273476
8.
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
Lancet Oncol
; 21(1): 80-94, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838009
9.
Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.
Br J Haematol
; 189(1): 117-121, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31682006
10.
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
Br J Haematol
; 189(6): 1093-1106, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32030738
11.
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Br J Haematol
; 190(3): 385-393, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150297
12.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256379
13.
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Lancet Oncol
; 20(2): 216-228, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630772
14.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Br J Haematol
; 187(3): 347-355, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31290569
15.
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Eur J Nucl Med Mol Imaging
; 46(1): 65-79, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30141066
16.
Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.
Eur J Nucl Med Mol Imaging
; 46(9): 1840-1849, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209514
17.
Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trial.
BMC Palliat Care
; 18(1): 85, 2019 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647011
18.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061295
19.
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
N Engl J Med
; 373(26): 2499-511, 2015 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26699166
20.
PET-CT: reliable cornerstone for Hodgkin lymphoma treatment?
Blood
; 127(12): 1521-2, 2016 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27013209